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Viral protein synthesis within host cells exerts a major influence upon T cell re-
sponses to influenza virus (1-4) . In general, class I MHC-restricted recognition is
favored by occurrence of viral biosynthesis while class II-restricted responses to the
same protein can be elicited by inert virions . The composition ofT cell populations
can be influenced by the infectivity of the viral antigen . In a recent study, Morrison
et al . (5) observed that in vitro restimulation of virus-primed murine splenocytes
with infectious virus yielded mainly class I MHC-restricted CTL, while noninfec-
tious virus under the same conditions induced primarily class II-restricted CTL.
Antigen processing appears to be required for presentation of many class I-(6-8)
and class II-(9-11) restricted influenza virus T cell determinants, although excep-
tions are known (12, 13) . Cellular events associated with viral protein biosynthesis
may favor presentation with class I molecules (reviewed in references 14 and 15) .
Forexample, Braciale and coworkers (16), usingavaccinia virus recombinant bearing
the hemagglutinin (HA)' gene of influenza virus, studied antigen recognition re-
quirements forclass I- andclass II-restrictedCTL clones . Although influenzaHA
was absent on input vaccinia, synthesis ofHA within target cells permitted lysis by
class I-restricted T cells while failing, during the same time interval, to sensitize
the cells for class II-mediated lysis . Although endogenous synthesis is evidently the
major introduction route of viral proteins for class I-restricted processing, viral repli-
cation requirements were able to be bypassed by pretreatment of influenza virions
to inactivate their receptor-destroying enzyme activity (17), although virus uptake
andfusion with cellular membranes was required forformation ofclass I target struc-
tures (8) . This appears to be an alternate means of engaging class I-associated pro-
cessing . On the other hand, class II-restricted responses reported so far showed no
such special requirements for utilization of antigens present on virus particles.
We now report evidence that certain class II MHC restricted T cell responses
to influenza virus structural proteins are strongly dependent upon viral infectivity.
This work was supported by U.S . Public Health Service grant AI-22961 from the National Institutes
of Health and a grant from RJR Nabisco.
I Abbreviations used in this paper . HA, hemagglutinin; HAU, hemagglutinin units ; NA, neuraminidase.
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T cell recognition of a determinant of the influenza neuraminidase (NA) envelope
glycoprotein was blocked by preventing viral biosynthesis. Although shown to be
a linear determinant restricted to I-Ed, the replication requirement is typical of a
class I-restricted site. Studies of two I-Ed-restricted determinants of the HA mole-
cule revealed that, although both can be generated from replication-inactive exoge-
nous virus, one determinant showed a 10-fold increase in expression in presence
of infectious virus while the other was only slightly enhanced. This enhancement
of presentation by infectious virus appears to depend upon individual properties
of T cell sites; data suggest a correlation to the lability of the determinant.
Materials and Methods
Viruses andAntigens.
￿
Influenza virus A/Puerto Rico/8/34 (PR8; H1N1) was grown in the
allantoic cavity of embryonated hen eggs and purified by sedimentation and banding on su-
crose density gradients. Virus concentration in hemagglutinating units (HAU) was deter-
mined by chicken red cell agglutination (18). Inactivation of virus replication was achieved
by exposure to short-wave UV light using a UVGLD58 Mineralight lamp (Ultraviolet Prod-
ucts, San Gabriel, CA) at 240 pW/cm2 for 15 min. Staining for viral antigens of Madin Darby
Canine Kidney cells exposed to dilutions of treated virus confirmed the effectiveness of the
inactivation. The vaccinia recombinant virus used to screen T cell hybridomas for neuramin-
idase specificity was generated by Dr. G. Smith (19) and was the generous gift of Dr. J . Yew-
dell, National Institutes of Health (Rockville, MD) . Purified HA/NA rosettes were prepared
by ammonium deoxycholate treatment of purified virus after the method ofLaver and Web-
ster (20). Purified bromelain-solubilized HA was prepared according to Brand and Skehel
(21). HA-free NA was purified from PR8 virus by the method of Gallagher et al. (22). Yield
of highly purified NA was very low and its use was restricted to quantitative immunoassays.
Protein concentrations of pure HA and NA were determined by quantitative amino acid
analysis.
Antibodies.
￿
The PR8 HA-specific mAb Y8-101 was previously described (23) and the type
B/Lee HA-specific mAb 1.309.4 were both kindly provided by Drs. Walter Gerhard and Peggy
Scherle, Wistar Institute, Philadelphia, PA. The monoclonal anti-neuraminidase antibody
NA2-1C1 was the generous gift of Dr. J. Yewdell, National Institutes of Health, Rockville,
MD. All of these antibodies (in the form of culture fluid) were of the IgGI isotype. Mono-
clonal rat anti-mouse IgGI was produced at the Wistar Institute by Dr. Louis Staudt. The
peroxidase conjugated mouse anti-rat mAb was purchased from Accurate Chemical & Scientific
Corp., Westbury, NY.
Cell Lines.
￿
The B cell lymphoma A20-1.11 (A20), a cloned APC, originally isolated and
described by Kim et al. (24), was the generous gift ofJ. Kappler (National Jewish Hospital,
Denver, CO). The protein synthesis inhibitors cycloheximide and emetine (Sigma Chemical
Co., St. Louis, MO) inhibited amino acid incorporation in these cells when used at indicated
concentrations. T cell hybridomas specific for two I-Ed-restricted determinants of PR8 HA
at residues 111-119 (site 1) and 302-313 (site 3) have been described (25-27).
The neuraminidase-specific T cell hybridoma NA-2.10 was generated by immunization
of BALL/c mice with PR8 virus as previously described (25) and screening of fused cells
with the NA-bearing recombinant vaccinia virus. The precise antigenic region of NA recog-
nized by these cells is not known.
All cells were cultured in Iscove's modified Dulbeccds medium (IMDM) containing 5%
(vol/vol) FCS.
Fixation ofAPC.
￿
The method ofAllen and Unanue (28) using freshly-made 0.5% (wt/vol)
paraformaldehyde was used with the modifications that have been described previously (11).
TCell Stimulation Assay.
￿
The ability ofAPC to stimulate influenza-specific T hybridomas
was tested as previously described (11). To isolate the effect of active viral protein synthesis
from potentially complicating factors, such as infection ofT cells or toxic effects ofthe virus,
A20 cells used as APC were pulsed briefly with influenza virus, fixed with paraformaldehyde
after various culture periods, and washed extensively before addition to T cell stimulationEISENLOHR AND HACKETT
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assays. The fixed A20 cells retained ability to be recognized by T cells and could be assayed
for expression of viral determinants. Briefly, APC that had been previously exposed to an-
tigen and were paraformaldehyde fixed were diluted two- or threefold in 96-well microtiter
plates from starting concentrations of 4 x 105 cells/well. Fixed APC or untreated APC (used
at 5 x 104 cells/well) plus antigen (for unpulsed APC) and T hybridomas (3 x 104 cells/well)
were co-incubated in serum-free IMDM at 37°C/6% C02 for 48 h. Culture supernatants
were assayed for IL-2 produced by stimulated T cells using the IL-2-dependent indicator
cell line CTLL (29). Viability of CTLL after co-incubation with the supernatants for 24-36 h
was quantitated by a modification of the original method of Mosmann (30) using cleavage
of the dye (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (31, 32). Color de-
velopment was measured using a platereader (model EL309; BioTek Instruments, Inc.,
Burlington, VT) at 570 nm (750 nm reference wavelength).
Assayfor Total Cellular HA and NA by ELISA.
￿
APC that had been pulsed with virus were
harvested by centrifugation, washed twice with PBS, and suspended at 107 cells/ml in ice-
cold 0.15 M sodium bicarbonate/carbonate buffer, pH 9.3, and 2 mM phenylmethylsulfonyl
fluoride. The cell suspension was then micro-tip probe sonicated at -80 watts (L Converter
probe sonicator; Bronson Sonic Power Co., Danbury, CN) on ice for 3 min. Lysates (25-p1
volumes) were then diluted into Costar Serocluster half-area EIA plates in twofold steps in
medium containing lysates of A20 cells (unpulsed cells lysed at the same density). Purified
PR8 virus and samples ofpurified HA and NA ofknown concentration were diluted in par-
allel. Wells were dried at room temperature followed by treatment with 0.5% gelatin in 0.15
M borate-buffered saline, pH 8.3. The wells were then tested for presence of HA and NA
by ELISA using mAbs (see above) specific for PR8 HA, NA, or, for negative controls, B/Lee
HA, followed by rat anti-IgG1 antibody and peroxidase-conjugated mouse anti-rat antibody.
The reactions were developed using the TMB Microwell Peroxidase Substrate Kit, Kirkegaard
& Perry Laboratories, Inc., Gaithersburg, MD, and absorbancies were measured at 450 nm
as described above.
Results
Replicatioe Virus Is Requiredfor Expression of the NA Determinant upon Antigen-pulsed
APC A20 cells were pulsed with the same concentration of PR8 influenza virus
which was either (a) infectious, (b) UVinactivated, or (c) infectious, but in presence
of the protein synthesis inhibitors cycloheximide or emetine. After 24 h in culture,
pulsed APC were paraformaldehyde fixed and placed in T cell assays with several
influenza-specific T hybridomas. Each of the T cells showed similar sensitivities to
antigen by IL-2 release in response to the same APC population (Fig. 1) . Fig. 1
a shows the response ofa T hybridoma recognizing a determinant of the NA. Most
notable is the complete absence of stimulation where virus had been rendered in-
capable of replicating its proteins within host cells either by UV or by presence of
protein synthesis inhibitors. The responses of two I-Ed-restricted T cells recognizing
influenza HA were tested upon the same APC groups. T cells recognizing sites in
the HA at amino acids 111-119 (site 1) and 302-313 (site 3) of the HAI polypeptide
(25, 33) are able to be stimulated by APC pretreated with either inactivated or infec-
tious virus (Fig. 1 b and c). However, APC pulsed with infectious virus showed a
greater stimulatory potency for both of the HA-specific T cells. The enhancement
of stimulation was nearly 10-fold for site 3-specific cells (Fig. 1 c) as opposed to a
slight increase observed for site 1 expression (Fig. 1 b). Since identical results are
obtained whether virus was inactivated by UV or by affectingprotein synthesis within
the host cell, differences in T cell stimulation appear to be based upon presence or
absence of newly synthesized viral proteins within APC .
The Appearance ofthe NA T Cell Determinant Follows Closely the Synthesis ofNA Protein924
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Effect of inhibition of viral protein
synthesis upon presentation ofTh determinants.
APC were pulsed with infectious or UV-inacti-
vated influenza PR8 virus and incubated 24 h be
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fore paraformaldehyde fixation. Cells pulsedwith
infectious virus were incubated with normal
medium or medium containing either 20 Wg/ml
cycloheximide or 10 AM emetine. The fixed APC
were tested for expression ofTh determinants in
T cell stimulation assays with the HA- and NA-
specific T hybridoma clones NA-2.10 (a, NA
specific); 3.21311 (b, HA/site 1 specific); and 2LD3-
11 (c HA/site 3 specific). APC were pulsed with
UV-treated virus (" ), or infectious virus in pres-
ence ofmedium only (O), cycloheximide (A), or
emetine (A).
within Infected Cells.
￿
To determine the relationship between viral protein synthesis
and Tcell determinant generation, the following timing experiment was performed.
APC were pulsed with infectious or UVinactivated virus and harvested after in-
tervals of incubation at 37'C. Aliquots at each time point were either: (a) lysed by
sonication and analyzed for the levels oftotal NA and HA by ELISA, or (b) fixed
with paraformaldehyde and placed inT cell stimulation assays to determine the rel-
ative amounts ofthethree determinants expressed at theAPC surface. Fig. 2 a shows
that newly synthesized NA appears between 4 and 8h post-infection. FRCS analysis
also showed the onset ofNA surface expression to occur in the same interval (data
not shown). The appearance of the T cell determinant, as indicated by ability of
the APC to stimulate the NA-specific T hybrid, occurs between 8 and 12 h post-
infection. Thus, the expression ofthe NAT celldeterminant follows the appearance
ofthe newly synthesized NA. This is contrasted with the onset of Th determinant
expression for HA site 1. In this case, ability to recognize exogenous antigen results
in initial appearance of the site T cell determinant occurring ahead ofthe appear-
ance of newly synthesized HA (Fig. 2 b).
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FIGURE 2.
￿
Kinetics of expression of
de novo synthesized viralproteins and
viral Th determinants. APC were
pulsed with infectious or UV-inacti-
vatedvirusandharvested at indicated
time points afterincubation at 37°C.
Aliquots were either paraformaldehyde
fixed and placed into T cell stimula-
tion assays, or lysedby sonication and
tested for viral protein expression in
ELISA. Data areexpressedas theper-
cent ofmaximalHA or NA protein ex-
pression or Tcell stimulation obtained
over thetime course oftheexperiment.
(a) Expression of NA protein (O) and
recognition by NA-specific T cell NA-
2.10 ofAPC pulsed with infectious(*)
or UV-treated virus (/). (b) Expres-
sion of HA protein (O) and recogni-
tion by HA/site 1-specific 3.21311 of
APCpulsed with infectious (")or UV
treated virus (N).
NA T Cell Determinant Expression by Infected APC Does not Correlate with Production
ofa Greater Quantity ofNA in Infected Cellsthan IsAvailableon Nonreplicative Virions. The
amount of NA present on virions and within infected A20 cells was quantitated.
Preparation ofultrasonicated and purified virus was mixed with a lysate of unin-
fected A20 cells and compared by ELISA with lysates ofA20 cells 24 h after infec-
tion with influenza virus. Table I shows that addition of 101 HAU of UV-treated
virions results in an 80-foldhigher concentration ofNA than arises in cells by infec-
tion, yet is unable to elicit recognition by the NA-specific clone.
The TCell Determinant Is Present in NA Isolatedfrom Egg-grownInfluenza Virions; Recog-
nition ofIsolatedMoleculesMay Bypass Cellular Processing Requirements. Totest whether
a neo-antigenrelatedto NA is recognized, NA was isolated from~purified egg-grown
PR8 virus and tested for its ability to be recognized by the NA-specificTcell clone.
A preparationofdetergent-solubilized HA/NA glycoproteinsfree ofinfectious virus
was recognized by the NA-specific T cell clone in concentrations ranging from
ti10-100-nM equivalents ofthe NA protein monomer (Table II). Although these
are much higher concentrations of NA than observed in stimulatory infected cell
cultures, concentrations ofNA on UV-treated virions within this range were non-
stimulatory (compare with Table I).
The ability ofextracted NA glycoprotein to be recognized by NA-specific Tcells
that do not respond to nonreplicative virus was studied further. Table III shows that
NAas part ofthe glycoproteinpreparation ispresentable byparaformaldehyde-prefixed
A20 cells, with or without reduction and alkylation of the preparation. Although926
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TABLE I
UV-inactivated Virions Containing a Higher NA Content than
Infected APC Fail to Stimulate NA-specific T Cells
Viral protein content was found to be 18.9 ng/HAU for HA and 270 pg/HAU
for NA by comparing ELISA values ofpurified virus with those obtained with
purified preparations of each glycoprotein at known concentration. Infected
A20 cells as used in the assay contained a virus equivalent of 280 HAU per
107 cells. Molecular masses of HA and NA protein monomers used in calcu-
lations were 70 and 50 kD, respectively (39). Antigen concentrations reflect
presence in cultures of 5 x 103 HAU/ml UV virus or 2 x 106/ml infected
APC .
T cell assays were performed with UV-treated virus or infected APC continu-
ously present in stimulation cultures. OD570 nm values reflect IL-2-dependent
growth of CTLL indicator cells, with assay background in absence of antigen
giving OC570 of 0.01-0.02 .
TABLE II
The Determinant Recognized by the NA-specific T Cell Clone Is
Present on Glycoprotein Purifiedfrom Egg-grown Influenza Virus
* Concentration of NA was determined by comparing ELISA values using
NA-specific mAbs obtained with the glycoprotein preparation to that of purified
NA of known protein concentration.
T hybridoma
NA-2.10
3.21111
TABLE III
Recognition of Isolated Influenza Glycoprotein Presented by
Untreated or Prefixed A20 Cells
T cell stimulation (OD570) in presence of:*
Untreated APC
￿
Pre-fixed APC
Reduced and
￿
Reduced and
Untreated alkylated Untreated alkylated
HA/NA HA/NA HA/NA HA/NA
0.446 0.148 0 .145 0.099
0.298 0.424 0 .034 0.224
* HA/NA rosettes were purified from virus and an aliquot reduced and alkylated
as described in Materials and Methods. 1:100 final dilutions (34 jig/ml) of these
preparations were cocultured with APC, untreated or pre-fixed, and the HA/site
1-specific 3.21111 or the NA-specific NA-2.10 in a standard T cell stimulation
assay. Responses threefold above assay background are underscored.
Concentration of
NA monomer in culture*
nM
Stimulation (OD570) of
NA-specific T hybrid
132 0.317
66 0.345
33 0.303
16 0.191
8 0.010
4 0.005
Antigen concentra- Stimulation (OD570) of
Antigen tion* in culture of: T cells recognizing:l
source HA NA HA NA
nM
UV virus 136 25 0 .263 0 .010
Infected cells 15 0 .3 0.250 0 .225EISENLOHR AND HACKETT
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the level of T cell stimulation is reduced on prefixed APC, this is seen also with
an HA-specificTcell, whichdiffers from the NA-recognizingclone in requiringreduc-
tion and alkylation forsensitization ofprefixed APC (Table III). Intact purifiedvirus
added to prefixed APC was not recognized by either HA- or NA-specific T cell clones
(not shown). These results suggest that the glycoprotein extraction procedure may
have the effect of"pre-processing" the region ofNA that contains theThdeterminant,
thereby allowing recognition ofisolated molecules in a way not possible for intact
virions.
Discussion
Class II MHC-restricted T cells specific for influenza virus structural proteins
were identified that respond much better to infectious than to noninfectious virus.
Expression ofa T cell determinant ofthe NA glycoprotein most strongly correlated
with viral infection. Several observations indicatethat theprotein ofexogenous virus
doesnot significantly contribute to formationofthatdeterminant. Firstly, NA-specific
T cell recognition was observed to trail the synthesis of viral NA within infected
APC. Secondly, quantitative studies showed that higher NA concentrations in cul-
tures could be achieved by addition of UVtreated virus than occurs by synthesis
within infected cells, yet without resultingin T cell recognition. Finally, NA extracted
by detergent treatment of egg-grown virions was recognized by T cells; however,
this preparation was able to sensitize pre-fixed APC from without, indicating that
the treated protein no longer required antigen handling by the APC. This suggests
that although the NA determinant is cryptically present on exogenous virions, the
normal antigen-handling pathway is ineffective in leading to its presentation.
Further, it seems unlikely that the concentration ofantigen within infected cells
underlies the effectivenessofinfectious virus. Themajorevidence forthisis the differen-
tial effect ofinfectivity observed for two T cell sites ofthe HA molecule. Expression
ofsite 3 was enhanced N10-fold on infected APC, while at the same time T cell rec-
ognition of HA site 1 was only slightly better than with an equivalent amount of
UVtreated virus. Bothdeterminants, locatedonthe same HAl polypeptide, should
beproduced in equimolar amounts within infectedcells, implicatingproperties other
than intracellular concentration in determining the relative contribution of en-
dogenously synthesized antigen to T cell recognition.
Available evidence suggests that the T cell sites that show greatest enhancement
as a result ofendogenous viral protein synthesis are the more labile determinants.
Considering HA sites 1 and 3, although both are linear determinants that require
APC function inhibitable bylysosomotropic agents oraldehyde prefixationfor their
generation from native virus (11), previous studies have shown that processing re-
quirements and expression characteristics of the two I-Ed-restricted determinants
greatly differ. Firstly, presence ofthediffusible protease inhibitorleupeptin decreases
presentation of site 1 while enhancing site 3 expression several fold (34). Secondly,
transient exposure ofvirusto pH 5, similarto the acidity encountered in endosomes,
efficiently sensitizes pre-fixed APC for recognition ofsite 3 but is not sufficient for
recognition ofsite 1 (35). Finally, studies ofthe kinetics of determinant expression
show that site 3 is expressed at maximal levels N8 h post-pulse with nonreplicative
virus and declines greatly by 48 h, while site 1 expression increases continuously
over that entire time period (34). From these observations, site 3 appears to have928
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fewerenzymaticrequirements for its presentation than site 1, while alsobeing sensi-
tive to destruction by leupeptin-inhibitable cellular enzymes and more readily turned
over by active APC. Although less information is available for the NA site, prelimi-
nary observations suggest that it may be relatively labile. Detergent extraction of
virion NA, while maintaining NA enzymatic activity, results in a "pre-processing"
ofthe molecule for T cell recognition. However, this preparation lost its ability to
sensitize pre-fixed APC for T cell recognition when briefly exposed to pH 5 under
conditions ofcalcium chelation (data not shown), which destroys sialidase activity
ofsubtype Nl NA(8). One speculation is that apresentation pathway linked to syn-
thesis maybypass thedestructive effects oftheendosome-lysosome system andthereby
enhance thelevels oflabile determinants. Alternatively, determinants that have short
half-lives on APC surfaces may benefit by beingcontinuously replaced from newly
synthesized material in infected APC, without invoking a unique pathway. It seems
likely that all Tcell determinants are presented byinfected APC, but that thegreatest
contrast is observed with those that survive less well when introduced on a single
pulse of antigen.
To date no direct evidence is available that nonoverlapping pathways are used to
present endogenous vs. exogenous antigen in association with MHC class II, orthat
the endogenous routecorresponds with that proposed forgeneration ofclass I MHC-
restricted determinants. Inconclusive results were obtained with chloroquine treat-
ment, often used todisable endosomal pathways (6, 10, 16, 36-38), since itsaddition
at intervals after infection greatlydecreasedviralprotein expression in infected cells
(data not shown) upon which recognition was shown to depend (Fig. 2). Mapping
ofthe routes utilized may depend upon availability ofinhibitors with more narrow
specificities. It is also possible that some apparent distinctions in the generation of
class I and class II MHC-restricteddeterminants mayinvolvedifferences in kinetics
of their appearance. For example, the observation by Morrison et al. (16) ofHA-
specificclass I- but not class II-restricted lysisofrecombinantvaccinia-infected targets
6-7 h post-infection could reflect a delayed appearance ofclass II target structures.
It may be relevant that our NA determinant was nearly undetectable until after 8
h post-infection with influenza virus.
The varying dependencies ofclass II-restricted Th determinants upon an endog-
enoussource ofantigenmaybe relevant tovaccination. Immunization with replication-
inactive virus may fail to elicit the same range of Th as results from the usual en-
counter withinfectious virus. This couldconceivablylead to a compromised response
of the Th compartment when challenged by natural infection.
Summary
The contribution ofviral infectivity to the expression ofMHC class II-restricted
T cell determinants was studied. A murine I-Ed-restricted T cell hybridoma recog-
nizing the neuraminidase (NA) glycoprotein ofinfluenza PR8 virus was stimulated
strongly by infectious virus but failed to recognize antigen introduced on noninfec-
tious virions. Recognition correlated with the de novo synthesis ofviral NA within
infected APC. The effectiveness ofinfectious virusdid not depend strictlyupon the
amount ofNA present in cultures, since high NA concentrations could be achieved
by addition ofnonreplicativevirus withoutbeing stimulatoryfor NA-specificT cells.
Recognition ofa determinant generated only when synthesized in murine host cellsEISENLOHR AND HACKETT
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was ruled out, since, in high concentration, NA isolated from purified egg-grown
virions, even if reduced and alkylated, was recognized by the T hybridoma clone.
Isolated NA was recognized when added to pre-fixed APC, suggesting that this form
of antigen was able to bypass the usual processing pathway of exogenous proteins.
Data suggest that endogenously synthesized antigen may contributemost significantly
to presentation of labile T cell determinants. In addition to NA, recognition of an
I-Ed-restricted determinant of the influenza hemagglutinin (HA) molecule, shown
previously to have a relatively short half-life on APC surfaces, was enhanced greatly
by infectious virus. In contrast, T cell recognition of a more stably expressed I-Ed-
restricted site of the same HA polypeptide was only marginally improved on in-
fected APC.
We thank Daniel Horowitz for technical assistance and Drs. Walter Gerhard and Esteban
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